Brand-Name Pharmaceutical Manufacturing in Canada - Industry Market Research Report
Description
Brand-Name Pharmaceutical Manufacturing in Canada
Brand-name pharmaceutical manufacturers in Canada have endured strong competitive pressures from generic drugs by innovating its product line and attracting higher demand from Canadians. In response to many brand-name drugs losing their patent protection, many companies have streamlined their operations. By forming networks with public or private companies and academic institutions, brand-name pharmaceutical manufacturers have been able to share research and development costs. This trend has been vital regarding investing in biopharmaceutical development, as exemplified by the rising investment in research and development in pharmaceutical companies. This has proved fruitful amid the COVID-19 pandemic, as companies have partnered together to quickly develop effective vaccines. Efficient vaccine manufacturing has supported revenue, but increasing generic drug usage has offset this trend. Revenue has decreased at a CAGR of 1.9% to $8.0 billion over the five years to 2023. This includes a forecast expansion of 0.7% in 2023 alone, as the economy continues to normalize in the wake of the pandemic.
The Brand-Name Pharmaceutical Manufacturing industry in Canada develops prescription and over-the-counter products used to treat illnesses in humans and animals. Brand-name drugs have patent protection. This industry does not include nutritional supplement or cosmetics manufacturers.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Brand-name pharmaceutical manufacturers in Canada have endured strong competitive pressures from generic drugs by innovating its product line and attracting higher demand from Canadians. In response to many brand-name drugs losing their patent protection, many companies have streamlined their operations. By forming networks with public or private companies and academic institutions, brand-name pharmaceutical manufacturers have been able to share research and development costs. This trend has been vital regarding investing in biopharmaceutical development, as exemplified by the rising investment in research and development in pharmaceutical companies. This has proved fruitful amid the COVID-19 pandemic, as companies have partnered together to quickly develop effective vaccines. Efficient vaccine manufacturing has supported revenue, but increasing generic drug usage has offset this trend. Revenue has decreased at a CAGR of 1.9% to $8.0 billion over the five years to 2023. This includes a forecast expansion of 0.7% in 2023 alone, as the economy continues to normalize in the wake of the pandemic.
The Brand-Name Pharmaceutical Manufacturing industry in Canada develops prescription and over-the-counter products used to treat illnesses in humans and animals. Brand-name drugs have patent protection. This industry does not include nutritional supplement or cosmetics manufacturers.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
44 Pages
- ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
